Delivery Order SPE2DB20D3103-SPE2DB24FM2L5

Award Date 1/11/24
Potential Completion Date 1/12/24
Potential Value $9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $5,340.35. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on May 3, 2023, with a ceiling value of $12,840.27 and a completion date of May 4, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. This contract award is not associated with a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VEMLIDY 25 MG TABLET UU 30S. The contract, valued at $2,700.75, is a firm fixed-price Delivery Order with a completion date of November 15, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up...
This federal contract award is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract, valued at $12,904.04, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 4, 2025. No set-aside designation was used for this...
This federal contract award is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,133.59 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 10, 2024. The contract has an ultimate completion date of December 11, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite...
The federal contract award is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $2,828.40 and an Ultimate Completion Date of January 23, 2025. The contract was awarded on January 22, 2025 and does not have a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of VEMLIDY 25 MG TABLET UU 30S. The $34,669.38 firm fixed-price delivery order contract has a completion date of January 10, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of VEMLIDY 25 MG TABLET UU 30S. The $4,386.34 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The Firm Fixed Price Delivery Order, valued at $33,240.43, is for the supply of 4558548926 - VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of September 22, 2022 and was awarded on September 21, 2022. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery...
This federal contract award, valued at $11,972.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of VEMLIDY 25 MG TABLET UU 30S, with an ultimate completion date of April 20, 2023. The contract has a Firm Fixed Price pricing type and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FM2L5
    Delivery Order

This federal contract award is for the delivery of VEMLIDY 25 MG TABLET UU 30S to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $8,978.36 and is a firm fixed-price delivery order with an ultimate completion date of January 12, 2024. This contract is not associated with a set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/13/25, 10:21 AM